SCHEMBL7557482

SCHEMBL7557482

CNc1c(C(=O)N(C)c2ccccc2)c(=O)[nH]c2ccc(C)c(OC)c12

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.36
TSHR P16473 1/20 0.34
ATM Q13315 1/20 0.33
KMT2A Q03164 5/20 0.33
MEN1 O00255 4/20 0.33
POLB P06746 2/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MAP3K5 Q99683 1/20 0.33
PGR P06401 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NPC1 O15118 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
HTT P42858 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565042 0.87 ALOX5 (0.36) PTGS2TSHRKMT2AMEN1MAPT
SCHEMBL7565085 0.86 KDM4E (0.40) PTGS2TSHRATMKMT2AMEN1
SCHEMBL7560668 0.78 POLB (0.45) PTGS2KMT2AMEN1POLBKDM4E
SCHEMBL7818937 0.75 PTGS2 (0.44) PTGS2KMT2AMEN1POLBMAPT
SCHEMBL7555419 0.74 PTGS2 (0.46) PTGS2ATMKMT2AMEN1POLB
SCHEMBL11291425 0.74 KDM4E (0.48) PTGS2KMT2AMEN1SMN1; SMN2TDP1
SCHEMBL6204567 0.73 HDAC4 (0.49) MAPTSMN1; SMN2ALDH1A1
SCHEMBL7556725 0.73 KMT2A (0.43) TSHRKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL7556606 0.73 MEN1 (0.43) TSHRKMT2AMEN1POLBMAPT
SCHEMBL7829055 0.72 PTGS2 (0.40) PTGS2TSHRKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 EP claimed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 WO claimed
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 EP disclosed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 WO disclosed